{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:56:25Z","timestamp":1794048985066,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejim.2017.11.010","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T22:00:40Z","timestamp":1511474440000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6969-4296","authenticated-orcid":false,"given":"Alon","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Feldhamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Meyerovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejim.2017.11.010_bb0005","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ejim.2017.11.010_bb0010","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ejim.2017.11.010_bb0015","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jc.2012-2180","article-title":"Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study","volume":"98","author":"Hyland","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ejim.2017.11.010_bb0020","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/jc.2011-2684","article-title":"Thyroid function and mortality in older men: a prospective study","volume":"97","author":"Waring","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.11.010_bb0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjmed.2015.11.027","article-title":"Subclinical thyroid disease and mortality in the elderly\u2013a retrospective cohort study","volume":"129","author":"Grossman","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ejim.2017.11.010_bb0030","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2011-1978","article-title":"Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk","volume":"97","author":"Nanchen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2017.11.010_bb0035","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1089\/105072503322238863","article-title":"Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey","volume":"13","author":"Lindeman","year":"2003","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.ejim.2017.11.010_bb0040","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/BF02598988","article-title":"Does treatment with l-thyroxine influence health status in middle-aged and older adults with subclinical hypothyroidism?","volume":"11","author":"Jaeschke","year":"1996","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.ejim.2017.11.010_bb0045","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1210\/jcem.86.10.7959","article-title":"Subclinical hypothyroidism is mild thyroid failure and should be treated","volume":"86","author":"McDermott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ejim.2017.11.010_bb0050","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1210\/jcem.86.10.7973","article-title":"TSH-controlled l-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study)","volume":"86","author":"Meier","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ejim.2017.11.010_bb0055","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.11.010_bb0060","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2017.11.010_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejim.2017.11.010_bb0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MED.0000000000000003","article-title":"When thyroid hormone replacement is ineffective?","volume":"20","author":"Benvenga","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.ejim.2017.11.010_bb0075","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0889-8529(05)70281-4","article-title":"Biochemical testing of thyroid function","volume":"26","author":"Klee","year":"1997","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejim.2017.11.010_bb0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/clinchem\/48.1.55","article-title":"Compliance of general practitioners with guideline-based decision support system for ordering blood tests","volume":"48","author":"Van Wijk","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejim.2017.11.010_bb0085","series-title":"Clinical chemistry: theory, analysis and correlation","first-page":"956","article-title":"Thyroxine","author":"Chen","year":"1989"},{"key":"10.1016\/j.ejim.2017.11.010_bb0090","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.ejim.2017.11.010_bb0095","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1210\/jc.2013-4184","article-title":"Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study","volume":"99","author":"Selmer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ejim.2017.11.010_bb0100","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1210\/jc.2013-1039","article-title":"Subclinical hypothyroidism and survival: the effects of heart failure and race","volume":"98","author":"Rhee","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ejim.2017.11.010_bb0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-16-0708","article-title":"Elevated TSH in adults treated for hypothyroidism is associated with increased mortality","volume":"176","author":"Akirov","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ejim.2017.11.010_bb0110","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9343(02)01022-7","article-title":"A 6-month randomized trial of thyroxine treatment in women with mild subclinical hypothyroidism","volume":"112","author":"Kong","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2017.11.010_bb0115","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ejim.2017.11.010_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archinte.1991.00400010159025","article-title":"Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism","volume":"151","author":"Sawin","year":"1991","journal-title":"Arch Intern Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517304685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T17:48:22Z","timestamp":1603388902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517304685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":24,"alternative-id":["S0953620517304685"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.11.010","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with levothyroxin in subclinical hypothyroidism is associated with increased mortality in the elderly","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}